Vilhardt H, Atke A, Barthova J, Ubik K, Barth T
Department of Medical Physiology, Univesity of Copenhagen, Denmark.
Pharmacol Toxicol. 1997 Sep;81(3):147-50. doi: 10.1111/j.1600-0773.1997.tb00045.x.
The results of the present study describe the course of reaction and the products following chymotrypsin treatment of the oxytocin analogue carbetocin ([1-deamino-1-monocarba-2-O-methyltyrosine]-oxytocin). The metabolites were analyzed and identified through TLC, HPLC and mass spectrometry. The main product emerging after treatment of carbetocin with chymotrypsin is 9-desglycineamide carbetocin indicating preferential hydrolysis of the peptide bond between leucine at position 8 and carboxyterminal glycineamide. At the same time the stability of the bond between tyrosine at position 2 and isoleucine at position 3 appears significantly enhanced through the alkylation of the hydroxyl group of tyrosine.
本研究结果描述了用胰凝乳蛋白酶处理催产素类似物卡贝缩宫素([1-脱氨基-1-单卡巴-2-O-甲基酪氨酸]-催产素)后的反应过程及产物。通过薄层色谱法、高效液相色谱法和质谱分析法对代谢产物进行了分析和鉴定。用胰凝乳蛋白酶处理卡贝缩宫素后出现的主要产物是9-去甘氨酰胺卡贝缩宫素,表明8位亮氨酸与羧基末端甘氨酰胺之间的肽键优先水解。同时,通过酪氨酸羟基的烷基化作用,2位酪氨酸与3位异亮氨酸之间的键的稳定性明显增强。